Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lemaitre Vascular Inc Issues Q1, FY 2013 Guidance Above Analysts' Estimates


Tuesday, 26 Feb 2013 04:05pm EST 

Lemaitre Vascular Inc announced that for the first quarter of 2013, it expects sales of $15.0 million and operating income of $0.7 million. For fiscal 2013, it expects sales of $61.5 million and operating income of $5.0 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $14.00 million and EBIT of $0.44 million for the first quarter of 2013; revenue of $60.0 million and EBIT of $4.23 million for fiscal 2013. 

Company Quote

7.88
-0.07 -0.88%
12:36pm EDT